Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
133.40    1.80 (1.37%)
Bid:
133.20
Ask:
133.80
Spread: 0.60 (0.45%)
Market Cap: £272.52m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Pre-close trading update

5 Jul 2016 07:00

RNS Number : 2031D
Forterra plc
05 July 2016
Β 

Forterra plc

Β 

Pre-close trading update

Β 

Forterra plc ("Forterra" or the "Company"), a leading UK producer of manufactured masonry products, provides this pre-close trading update with respect to its half year ended 30 June 2016.

Β 

Overall, the profit for the first half is in line with management's expectations at the time of the IPO in April 2016 and, as anticipated, brick sales volumes were weighted towards house builders. Sales to the builders' merchants have been affected by excess inventory continuing to be held by the merchant sector. The Group continued to generate a strong level of operating cash flow and net debt at the end of June was around Β£20m better than expectations.

Β 

Given current economic uncertainty and sufficient brick inventory levels, the Board has reviewed the current production plan and has decided to maximise the utilisation of our most efficient brick plants and effectively manage our cost base.

Β 

The Company will therefore enter into consultation with employees at its brick factories in Accrington and Claughton, in Lancashire, proposing to temporarily mothball the plants. Β This is a prudent action that will allow us to continue to meet customers' needs while effectively managing our costs and cash position until we are able to more effectively forecast demand.

Β 

Both of these brick plants were mothballed between 2010 and 2014 and the Company has demonstrated its capability to successfully bring production back online in a short period of time.

Β 

Forterra has sufficient brick inventory and production capacity to service customer demand should housing output continue to grow as previously expected.

Β 

The Board continues to believe that in the medium term the fundamentals driving demand for our products are attractive and isΒ confident that Forterra's strategy will drive value for shareholders. We will provide an update on the market outlook with our interim results on 7 September 2016.

Β 

Β 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

Β 

Forterra plc

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

Β 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBLGDRGDGBGLS
Date   Source Headline
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration
31st Oct 20225:01 pmRNSTotal Voting Rights
31st Oct 20222:54 pmRNSDirector/PDMR Shareholding
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
6th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20226:26 pmRNSEmployee Benefit Trust Share Purchase
4th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20225:40 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.